Article (Scientific journals)
Transformation by deltaretroviruses: mechanisms and therapies
Willems, Luc
2012In Proceedings of the Belgian Royal Academies of Medicine, 1, p. 157-165
Peer Reviewed verified by ORBi


Full Text
Willems ARMB final.pdf
Publisher postprint (343.06 kB)
Request a copy

All documents in ORBi are protected by a user license.

Send to


Keywords :
retrovirus; oncogene; histone deacetylase; vaccine; checkpoint
Abstract :
[en] Human T-lymphotropic virus type 1 (HTLV-1) and bovine leukemia virus (BLV) are two closely related deltaretroviruses inducing hematological diseases in human and ruminants. HTLV-1 infects about 25 million subjects worldwide and causes Adult T-cell leukemia-lymphoma (ATLL) or HAM/TSP (HTLV-induced myelopathy - tropical spastic paraparesis). BLV is the etiological agent of enzootic bovine leukemia. HTLV-1 and BLV have developed strategies to subvert hosts' immune surveillance. Understanding these mechanisms has allowed development of novel therapeutic approaches.
Disciplines :
Author, co-author :
Willems, Luc  ;  Université de Liège - ULiège > Chimie et bio-industries > Biologie cell. et moléc.
Language :
Title :
Transformation by deltaretroviruses: mechanisms and therapies
Publication date :
Journal title :
Proceedings of the Belgian Royal Academies of Medicine
Publisher :
Koninklijke Academie voor Geneeskunde van België, Académie Royale de Médecine de Belgique., Bruxelles, Belgium
Volume :
Pages :
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique [BE]
Commentary :
This work was supported by the “Fonds National de la Recherche Scientifique” (FNRS), the Télévie, the Belgian Foundation against Cancer, the Sixth Research Framework Programme of the European Union (project INCA LSHC-CT-2005-018704), the “Neoangio” excellence program and the “Partenariat Public Privé” PPP INCA of the “Direction générale des Technologies, de la Recherche et de l’Energie/DG06” of the Walloon government, the “Action de Recherche Concertée Glyvir” of the “Communauté française de Belgique”, the “Fonds spéciaux pour la Recherche” of the University of Liège (ULg), the Synbiofor program of GxABT (ULg), the “Centre anticancéreux près ULg” (CAC), the “Plan Cancer” of the “Service Public Fédéral” and the Interuniversity Attraction Poles (IAP) Phase VII BELVIR.
Available on ORBi :
since 20 August 2013


Number of views
82 (19 by ULiège)
Number of downloads
1 (1 by ULiège)


Similar publications

Contact ORBi